Prostate cancer Board decisions

The Veteran does not have a back disability, hydronephrosis, or prostate cancer that is related to active service.

The Veteran's claim for service connection for prostate cancer is being remanded due to the need for additional development, including obtaining his complete service personnel records and pay records. The Veteran may have served in Vietnam but there are outstanding records that need to be obtained.

The Veteran's claim for special monthly pension based on the need for regular aid and attendance was denied as he does not meet the criteria for permanent aid and assistance due to his disabilities.

The Veteran's prostate cancer is being remanded for further evaluation due to the need for a VA examination and medical opinion regarding its etiology. The appeal will be considered based on direct service connection, as there is no evidence of herbicide exposure.

The Board found that the Veteran's service-connected residuals of prostate cancer warranted a 40% rating for portions of the appeal period from December 6, 2005, to September 24, 2007, and from January 12, 2011. The reduction was denied as improper.

The Board has decided to remand the case for additional development, including obtaining private medical records and an opinion regarding the cause of the Veteran's death.

The Board has reopened the claim for service connection for the cause of the Veteran's death due to new evidence submitted by the appellant. However, it is determined that the Veteran's prostate cancer was not incurred or aggravated by active duty service and his exposure to chemicals.

The Veteran's claims for service connection are being remanded due to the need for a statement of the case on his hypertension and hypothyroidism secondary to type II diabetes mellitus, as well as his postoperative residuals of prostate cancer and type II diabetes mellitus.

The Veteran's prostate cancer is being remanded for further development of his personnel records to determine if he served in Vietnam and had any exposure to herbicides. The claim will be reconsidered based on the new information.

The Board has determined that the Veteran was not exposed to Agent Orange in service and therefore, his cause of death is not related to service. As a result, service connection for the cause of the Veteran's death is denied.

The Board denied the claim for service connection for prostate cancer as secondary to ionizing radiation exposure, finding that there was no evidence of a current disability and noting that the appellant's prostate cancer is not presumed due to or shown to be the result of in-service ionizing radiation exposure.

The Board has remanded the case for further development, including obtaining a dose estimate of the Veteran's exposure to radiation and an opinion on whether it is at least as likely as not that his prostate cancer was due to occupational exposure to ionizing radiation.

The Board has determined that further development is needed to confirm the Veteran's exposure to chemicals and radiation during his service at Eareckson Air Station in Alaska. Additionally, a VA examination is required for tinnitus and right ear hearing loss.

The Veteran's coronary artery disease, prostate cancer, and diabetes mellitus type II are presumed to be related to his in-service herbicide exposure.

The Veteran's service-connected chronic prostatitis is rated at 60 percent, the highest available rating for urinary leakage or incontinence requiring use of an appliance or wearing absorbent materials more than four times a day.

The Veteran's claim for service connection for venous stasis dermatitis and prostate cancer was denied. The Board found that the evidence did not support a direct link between these conditions and his military service.

The Veteran's service-connected residuals of prostate cancer, which were previously rated at 100%, are now rated at 40% effective June 1, 2008. The appeal is for a higher rating during the period from June 1, 2008 to July 14, 2009.

The Veteran's appeal is remanded due to the need for a VA examination to determine if his prostate cancer is related to service, specifically exposure to DDT during military service in Okinawa. The case will be returned to the Board after further development.

The Veteran's prostate cancer residuals have been rated at 40 percent since August 13, 2010. This rating reflects the Veteran's daytime voiding interval of less than one hour and his need to awaken to urinate five or more times per night.

The Veteran's appeal is being remanded for additional development, including VA examinations to assess the severity of his service-connected conditions and obtain relevant medical records.